26 May 2013
Keywords: roche, mabthera, approved, cll, swiss, drug, major
Article | 09 March 2009
Swiss drug major Roche says that the European Commission has approved
MabThera (rituximab) in combination with chemotherapy for use in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 March 2009
24 May 2013
© 2013 thepharmaletter.com